Alpine Immune Sciences, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Alpine Immune Sciences, Inc.
Quantité totale PI 87
Rang # Quantité totale PI 15 864
Note d'activité PI 2,7/5.0    59
Rang # Activité PI 12 301
Symbole boursier
ISIN US02083G1004
Capitalisation 4,499M  (USD)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

46 0
18 0
23 0
0
 
Dernier brevet 2026 - Cd86 variant immunomodulatory pr...
Premier brevet 2016 - Immunomodulatory proteins with t...

Derniers inventions, produits et services

2025 Invention Cd86 variant immunomodulatory proteins and uses thereof. Provided herein are variant CD86 polype...
Invention Pd-l1 variant immunomodulatory proteins and uses thereof. Provided herein are immunomodulatory p...
Invention Ctla-4 variant immunomodulatory proteins and uses thereof. Provided herein are variant CTLA-4 po...
Invention Multi-domain immunomodulatory proteins and methods of use thereof. Provided herein are multi-dom...
2024 Invention April and baff inhibitory immunomodulatory proteins and methods of use thereof. Provided herein ...
Invention Icos ligand variant immunomodulatory proteins and uses thereof. Provided herein are immunomodula...
Invention April and baff inhibitory immunomodulatory proteins and methods of use thereof. Provided herein a...
Invention Pd-1 variant immunomodulatory proteins and uses thereof. Provided herein are immunomodulatory pr...
2023 Invention Methods and uses of taci-fc fusion immunomodulatory protein
Invention Mutated taci-fc fusion proteins for use in the treatment of autoantibody-mediated diseases. Provi...
Invention Cd80 variant immunomodulatory proteins and uses thereof. Provided herein are variant CD80 polype...
Invention Immunomodulatory proteins of variant cd80 polypeptides, cell therapies and related methods and us...
Invention Immunomodulatory proteins of variant cd80 polypeptides, cell therapies thereof and related method...
Invention Variant icos ligand immunomodulatory proteins and related compositions and methods. Provided here...
2022 Invention Cd155 variant immunomodulatory proteins and uses thereof. Provided herein are immunomodulatory pr...
Invention Cd80 variant immunomodulatory proteins and uses thereof. Provided herein are variant CD80 polypep...
Invention Methods of dosing and treatment with a taci-fc fusion immunomodulatory protein. Provided herein ...
Invention Methods of dosing and treatment with a taci-fc fusion immunomodulatory protein. Provided herein a...
Invention Immunomodulatory proteins with tunable affinities. Provided are immunomodulatory proteins and nuc...
2021 Invention April and baff inhibitory immunomodulatory proteins with and without a t cell inhibitory protein ...
2020 Invention Icos ligand variant immunomodulatory proteins and uses thereof. Provided herein are immunomodulat...
Invention Methods and uses of variant icos ligand (icosl) fusion proteins. Provided herein are immunomodul...
2019 Invention Cd86 variant immunomodulatory proteins and uses thereof. Provided herein are variant CD86 polypep...
Invention Methods and uses of variant cd80 fusion proteins and related constructs. Provided herein are var...
Invention Pd-1 variant immunomodulatory proteins and uses thereof. Provided herein are immunomodulatory pro...
Invention Multi-domain immunomodulatory proteins and methods of use thereof. Provided herein are multi-doma...
2018 Invention Ctla-4 variant immunomodulatory proteins and uses thereof. Provided herein are variant CTLA-4 pol...
Invention Pd-l1 variant immunomodulatory proteins and uses thereof. Provided herein are immunomodulatory pr...
2017 Invention Cd112 variant immunomodulatory proteins and uses thereof. Provided herein are immunomodulatory pr...